Clinical Trials Logo

Clinical Trial Summary

To study the effective treatment of sudden deafness by giving prednisone, hyperbaric oxygen and somatosensory stimulation to sudden deafness patients.


Clinical Trial Description

60 cases of sudden deafness within 2 months of 14-80 years old were randomly divided into two groups. They underwent hearing tests, magnetic resonance imaging of the head, and routine hospital admissions. One group was given prednisone for 1 mg / kg body weight × 7 days + somatosensory stimulation × 30 days, the other group was given prednisone for 1 mg / kg body weight × 7 days + hyperbaric oxygen × 15 days, and repeated electrical audiometry every week. One month and three months after the experiment, repeated audiometry. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04129983
Study type Interventional
Source The First Affiliated Hospital of Anhui Medical University
Contact Dan Su, master
Phone +8615755149100
Email sudan19966991@outlook.com
Status Not yet recruiting
Phase N/A
Start date June 2020
Completion date October 2020

See also
  Status Clinical Trial Phase
Completed NCT02414152 - Study of the Effects of Anakinra in Corticosteroid-resistant Subjects With Sudden Sensorineural Hearing Loss Phase 1/Phase 2
Completed NCT05052944 - Single-sided Deafness and Cochlear Implantation
Not yet recruiting NCT05786378 - Assessment of The Efficacy of Intratympanic Platelet Rich Plasma for Treatment of Sensorineural Hearing Loss. Phase 2/Phase 3
Recruiting NCT04766853 - Verification of the Efficacy/Safety of the Intratympanic Drug Delivery for Hearing Loss Phase 1/Phase 2
Recruiting NCT05474963 - Sudden Sensorineural Hearing Loss in Wonju Severance Christian Hospital
Not yet recruiting NCT06437054 - Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss Phase 1/Phase 2
Not yet recruiting NCT06365775 - Multi-omics Characteristics and Prognosis of Idiopathic Sudden Sensorineural Hearing Loss
Recruiting NCT05455398 - Establishment of a Trans-round Window Inner Ear Continuous Drug Delivery System for the Treatment of Severe-to-profound Sudden Sensorineural Hearing Loss N/A